On Monday, Health Care REIT, Inc. (NYSE:HCN)’s shares inclined 1.25% to $71.14.
Health Care REIT, Inc. (HCN) declared operating results for the company’s first quarter ended March 31, 2015.
Dividend Growth As formerly declared, the Board of Directors declared a cash dividend for the quarter ended March 31, 2015 of $0.825 per share, as contrast to $0.795 per share for the same period in 2014, representing a 4% enhance. On May 20, 2015, we will pay our 176th successive quarterly cash dividend. The declaration and payment of quarterly dividends remains subject to review by and approval of the Board of Directors.
Earnings Results For the quarter, we generated normalized FFO and FAD per share of $1.04 and $0.92, respectively. First quarter results were influenced by the February equity raise, decreasing our leverage to 37.3% net debt to undepreciated book capitalization, concluding $2.2 billion of high-quality investments and total same store NOI growth of 3.1%. Same store NOI for seniors housing operating was 3.0% for the quarter and was negatively influenced by the unusually harsh winter and flu season.
Outlook for 2015 We are affirming our 2015 earnings guidance and expect to report normalized FFO in a range of $4.25 to $4.35 per diluted share, representing a 3%-5% enhance, and normalized FAD in a range of $3.83 to $3.93 per diluted share, representing a 5%-7% enhance. Our guidance comprises the impact of the February equity raise and reduced leverage for 2015. Additionally, in preparing our guidance, we have updated the following assumptions:
- Same Store Cash NOI: We continue to expect blended same store cash NOI growth of about 3.0%-3.5% in 2015.
- Acquisitions: 2015 earnings guidance does not comprise any acquisitions beyond what has been declared, counting those accomplished in the first quarter and investments associated with the Mainstreet partnership.
- Development: We anticipate funding additional development of $230 million in 2015 regardingprojects underway on March 31, 2015. We expect development conversions of about $190 million in the remainder of 2015. These investments are presently predictable to generate initial yields of about 8.3% upon conversion.
Health Care REIT, Inc. is an independent equity real estate investment trust. The firm engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets. It primarily invests in the real estate markets of the United States. The firm primarily invests in senior living and health care properties.
Sinclair Broadcast Group Inc (NASDAQ:SBGI)’s shares gained 1.20% to $30.40.
Sinclair Broadcast Group Inc (SBGI) declared that in celebration of its 20 years as a publicly-traded Company, it will ring The Nasdaq Stock Market Closing Bell on June 5, 2015 at 4:00pm ET. Earlier that day, the Company will host a sell-side Analyst Event from 10:00am to 12:00pm. Investors and the public are welcome in a listen-only mode via webcast accessible at www.sbgi.net.
Sinclair Broadcast Group, Inc., a diversified television broadcasting company, owns and operates, programs, or provides sales services to television stations in the United States. It broadcasts free over-the-air programming, such as network offered programs, news produced locally, local sporting events, programming from program service arrangements, syndicated entertainment programs, and other locally produced programs.
At the end of Monday’s trade, JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO)‘s shares dipped -2.01% to $8.30.
JA Solar Holdings Co., Ltd. (ADR) (JASO) declared that it has signed a Memorandum of Understanding (the “MOU”) with its Indian business partner, Essel Infraprojects Limited (“EIL”), to establish a solar cell and module manufacturing facility joint venture (“JV”). The MOU declares a 500MW production capacity for the JV and outlines the duties of each party.
The agreement was reached on May 16 th at the India-China Business Forum held in Shanghai , where Indian Prime Minister Narendra Modi , Chinese national leaders, and commercial and industrial representatives of both countries were in attendance, counting JA Solar and its partner, EIL.
Cooperation opportunities in the photovoltaic industry were a special focus at the Forum, as the leaders agreed that the establishment of a photovoltaic park should be a priority on the agenda. More than twenty different agreements were signed by representatives at the forum, representing up to 22 billion U.S. dollars in total investments.
JA Solar Holdings Co., Ltd., together with its auxiliaries, designs, develops, manufactures, and sells photovoltaic solar cells and solar power products based on crystalline silicon technologies.
Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI), ended its Monday’s trading session with -9.81% loss, and closed at $7.08.
Plasmatech Biopharmaceuticals Inc (PTBI) declared recently that the U.S. Food and Drug Administration (FDA) had granted both Orphan Drug Designation and Rare Pediatric Disease Designation for both of PlasmaTech Biopharmaceuticals’ lead product candidates for the treatment of Sanfilippo Syndromes A and B.
PlasmaTech Biopharmaceuticals, Inc. operates as a biopharmaceutical company and develops protein biologic therapies and oncology supportive care products. The companys marketed product comprises MuGard the administration of oral mucositis; and ProctiGard for the treatment of radiation proctitis, a frequent side effect of radiation treatment to the pelvic region. It also develops CobOral, a mediated oral delivery technology that utilizes the bodys natural vitamin B12 transport system in the gut; and CobaCyte, a mediated targeted delivery technology that has application in in tumor targeting.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
